Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRBS.L Regulatory News (RBS)

  • There is currently no data for RBS

Post-stabilisation announcement

25 Sep 2013 12:40

RNS Number : 8650O
UBS Limited
25 September 2013
 



Post-stabilisation announcement

 

 

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

 

 

DIRECT LINE INSURANCE GROUP PLC

Stabilisation Notice

 

 

 

UBS Limited (contact: Gareth McCartney ; telephone: 0044 20756 82227), in its capacity as Stabilisation Manager, hereby gives notice that no Stabilisation (within the meaning of the rules of the Financial Conduct Authority) was undertaken by the Stabilisation Manager named in relation to the offer of the following securities.

 

The Securities:

Vendor:

Royal Bank of Scotland Group plc

Underlying shares:

Direct Line Insurance Group plc

ISIN:

GB00B89W0M42

Base size:

272.7 million shares

Offer price:

210 pence

Maximum size of over-allotment facility:

10% of the aggregate nominal amount stated above

 

In connection with its Stabilisation activities, Royal Bank of Scotland Group plc granted UBS Limited, on behalf of the Underwriters, an over-allotment option, exercisable once for a period of 30 days after the announcement of the Offer Price on 20 September 2013 which, if exercised would require Royal Bank of Scotland Group plc to sell up to 10 per cent. of the aggregate number of Offering Shares available in the Offering (before any exercise of the Over-allotment Option) at the Offer Price to cover short positions arising from such over-allotments (if any) and/or sales of shares effected by it during the Stabilisation period.

 

UBS Limited agreed with Royal Bank of Scotland Group plc that any over-allotment of the Offering Shares by it or any of its agents will be up to a maximum of 10 per cent. of the total number of the Offering Shares (before any exercise of the Over-allotment Option).

 

Number of Offering Shares: 272.7 million

Number of shares subject to the over-allotment option: 27.3 million

 

No stabilisation trades have or will take place.

 

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

 

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

 

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

 

The offer of the above securities and the distribution of this announcement and other information in connection with the offer of the above securities in certain jurisdictions may be restricted by law and persons into whose possession any document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

 

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STANKPDNKBKDOCB
Date   Source Headline
10th Jul 201710:05 amRNSHolding(s) in Company
6th Jul 201711:03 amRNSTotal Voting Rights
30th Jun 20175:38 pmRNSAllotment and Issue of New Ordinary Shares
30th Jun 20171:24 pmRNSTotal Voting Rights
16th Jun 20178:19 amRNSCapital reorganisation - notice of completion
15th Jun 20176:21 pmRNSRBS welcomes credit rating upgrade by Moody's
8th Jun 20172:00 pmRNSDirector/PDMR Shareholding
2nd Jun 20172:12 pmRNSBlock Listing Cancellation
1st Jun 201710:15 amRNSDirector Declaration
31st May 20175:36 pmRNSDividend Declaration
31st May 20172:55 pmRNSTotal Voting Rights
30th May 20178:00 amRNSDeutsche Bank Global Financial Services Conference
16th May 20175:08 pmRNSCapital Reorganisation - notice of petition
12th May 20172:00 pmRNSDirector/PDMR Shareholding
11th May 20176:03 pmRNSResult of AGM
11th May 20171:55 pmRNSAGM Statement
11th May 20171:45 pmRNSDirectorate Change
11th May 201710:30 amRNSRBSG priced $3.0 billion Senior Notes
9th May 20175:40 pmRNSPublication of Supplementary Prospectus
28th Apr 20175:55 pmRNSRBS Holdings N.V. and Royal Bank of Scotland N.V.
28th Apr 20175:25 pmRNSPublication of Supplementary Prospectus
28th Apr 201710:50 amRNSTotal Voting Rights
28th Apr 20177:00 amRNS1st Quarter Results
25th Apr 20175:36 pmRNSDividend Declaration
24th Apr 20175:30 pmRNSAllotment and Issue of New Ordinary Shares
19th Apr 20174:48 pmRNSBlock listing Interim Review
6th Apr 20172:00 pmRNSNotice of AGM
31st Mar 20172:37 pmRNSNotices of Redemption
31st Mar 20172:10 pmRNSTotal Voting Rights
27th Mar 201711:05 amRNSFiling of Annual Report on Form 20F with SEC
21st Mar 20179:30 amRNSMorgan Stanley European Financials Conference
8th Mar 20172:30 pmRNSDirector/PDMR Shareholding
6th Mar 20174:59 pmRNSPublication of Final Terms
28th Feb 20172:40 pmRNSTotal Voting Rights
27th Feb 20174:45 pmRNSDirector/PDMR Shareholding
27th Feb 20173:00 pmRNSAdditional Listing
24th Feb 20175:22 pmRNSPublication of Suppl.Prospcts
24th Feb 20177:06 amRNSDirectorate Change
24th Feb 20177:01 amRNSAnnual Financial Report
24th Feb 20177:00 amRNSFinal Results
23rd Feb 201712:25 pmRNSDividend Declaration
20th Feb 20177:00 amRNSUpdate on RBS's remaining State Aid obligation
31st Jan 20173:37 pmRNSTotal Voting Rights
26th Jan 20177:00 amRNSAdditional provision for US RMBS investigations
3rd Jan 20173:00 pmRNSRing-fencing Legal Entity Transfers
30th Dec 201611:43 amRNSTotal Voting Rights
16th Dec 20166:04 pmRNSPublication of a Prospectus
9th Dec 20168:30 amRNSRBS Investor Seminar
5th Dec 20167:00 amRNSMajority settlement of 2008 shareholder Litigation
30th Nov 20162:36 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.